Probiotics suppress LL37 generated rosacea-like skin inflammation by modulating the TLR2/MyD88/NF-κB signaling pathway

Ligilactobacillus salivarius 23-006 and Lacticaseibacillus paracasei 23-008 ameliorated rosacea-like inflammation in mice through modulation of the gut microbiota and the TLR2/MyD88/NF-κB pathway.